Literature DB >> 21062060

The Cys319 loop modulates the transition between dehydrogenase and hydrolase conformations in inosine 5'-monophosphate dehydrogenase.

Helen R Josephine1, Kanchana R Ravichandran, Lizbeth Hedstrom.   

Abstract

X-ray crystal structures of enzyme-ligand complexes are widely believed to mimic states in the catalytic cycle, but this presumption has seldom been carefully scrutinized. In the case of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase (IMPDH), 10 structures of various enzyme-substrate-inhibitor complexes have been determined. The Cys319 loop is found in at least three different conformations, suggesting that its conformation changes as the catalytic cycle progresses from the dehydrogenase step to the hydrolase reaction. Alternatively, only one conformation of the Cys319 loop may be catalytically relevant while the others are off-pathway. Here we differentiate between these two hypotheses by analyzing the effects of Ala substitutions at three residues of the Cys319 loop, Arg322, Glu323, and Gln324. These mutations have minimal effects on the value of k(cat) (≤5-fold) that obscure large effects (>10-fold) on the microscopic rate constants for individual steps. These substitutions increase the equilibrium constant for the dehydrogenase step but decrease the equilibrium between open and closed conformations of a mobile flap. More dramatic effects are observed when Arg322 is substituted with Glu, which decreases the rates of hydride transfer and hydrolysis by factors of 2000 and 130, respectively. These experiments suggest that the Cys319 loop does indeed have different conformations during the dehydrogenase and hydrolase reactions as suggested by the crystal structures. Importantly, these experiments reveal that the structure of the Cys319 loop modulates the closure of the mobile flap. This conformational change converts the enzyme from a dehydrogenase into hydrolase, suggesting that the conformation of the Cys319 loop may gate the catalytic cycle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21062060      PMCID: PMC3005847          DOI: 10.1021/bi101590c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 2.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase.

Authors:  P Kuzmic
Journal:  Anal Biochem       Date:  1996-06-01       Impact factor: 3.365

4.  Genetic and biochemical studies of the guanosine 5'-monophosphate pathway in Escherichia coli.

Authors:  H J Nijkamp; P G De Haan
Journal:  Biochim Biophys Acta       Date:  1967-08-22

5.  Drug selectivity is determined by coupling across the NAD+ site of IMP dehydrogenase.

Authors:  J A Digits; L Hedstrom
Journal:  Biochemistry       Date:  2000-02-22       Impact factor: 3.162

6.  Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.

Authors:  Glen L Prosise; Jim Zhen Wu; Hartmut Luecke
Journal:  J Biol Chem       Date:  2002-09-13       Impact factor: 5.157

7.  Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction.

Authors:  Yollete V Guillén Schlippe; Thomas V Riera; Mohammad R Seyedsayamdost; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2004-04-20       Impact factor: 3.162

8.  Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.

Authors:  Glen L Prosise; Hartmut Luecke
Journal:  J Mol Biol       Date:  2003-02-14       Impact factor: 5.469

9.  The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase.

Authors:  Lu Gan; Mohammad R Seyedsayamdost; Satoshi Shuto; Akira Matsuda; Gregory A Petsko; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2003-02-04       Impact factor: 3.162

10.  Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid.

Authors:  M D Sintchak; M A Fleming; O Futer; S A Raybuck; S P Chambers; P R Caron; M A Murcko; K P Wilson
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

View more
  5 in total

1.  Allosteric activation via kinetic control: potassium accelerates a conformational change in IMP dehydrogenase.

Authors:  Thomas V Riera; Lianqing Zheng; Helen R Josephine; Donghong Min; Wei Yang; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2011-09-09       Impact factor: 3.162

Review 2.  The dynamic determinants of reaction specificity in the IMPDH/GMPR family of (β/α)(8) barrel enzymes.

Authors:  Lizbeth Hedstrom
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-02-15       Impact factor: 8.250

3.  De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans.

Authors:  Carl A Morrow; Eugene Valkov; Anna Stamp; Eve W L Chow; I Russel Lee; Ania Wronski; Simon J Williams; Justine M Hill; Julianne T Djordjevic; Ulrike Kappler; Bostjan Kobe; James A Fraser
Journal:  PLoS Pathog       Date:  2012-10-11       Impact factor: 6.823

4.  Structure of Pseudomonas aeruginosa inosine 5'-monophosphate dehydrogenase.

Authors:  Vincenzo A Rao; Sharon M Shepherd; Richard Owen; William N Hunter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-02-22

Review 5.  Gates of enzymes.

Authors:  Artur Gora; Jan Brezovsky; Jiri Damborsky
Journal:  Chem Rev       Date:  2013-04-25       Impact factor: 60.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.